Scaavrh74.tmck.hsgca (DrugBank: -)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
113 | 筋ジストロフィー | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01976091 (ClinicalTrials.gov) | February 2015 | 24/7/2013 | Gene Transfer Clinical Trial for LGMD2D (Alpha-sarcoglycan Deficiency) Using scAAVrh74.tMCK.hSGCA | Phase I/IIa Gene Transfer Clinical Trial for LGMD2D (Alpha-sarcoglycan Deficiency) Using scAAVrh74.tMCK.hSGCA | Limb Girdle Muscular Dystrophy Type 2D (LGMD2D) | Drug: scAAVrh74.tMCK.hSGCA | Jerry R. Mendell | NULL | Completed | 7 Years | N/A | All | 6 | Phase 1;Phase 2 | United States |